| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 04/07/2005 | US20050074774 Multiplex detection compositions, methods, and kits |
| 04/07/2005 | US20050074773 Methods for diagnosing and treatment of conditions that alter phosphate transport in mammals |
| 04/07/2005 | US20050074772 Alpha -2A-adrenergic receptor polymorphisms |
| 04/07/2005 | US20050074771 For attachment to steroids, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins; for detecting RNA in samples |
| 04/07/2005 | US20050074767 Using transcriptional activity of obesity genes as diagnostic indicator of efficacy of dietetic modulators; treating eating/weight disorders |
| 04/07/2005 | US20050074766 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 04/07/2005 | US20050074764 Using presence of point mutations in nicotinic acetylcholine receptor (nACHR) gene as diagnostic/prognosic tool in detction and treatment of indicator of cardiovascular, nervous system, vision and pain disorders |
| 04/07/2005 | US20050074762 Nucleotide sequences coding hormone protein for use in prevention and treatment of arteriosclerosis, diabetes, obesity and liver disorders |
| 04/07/2005 | US20050074761 Novel means for the diagnosis and therapy of ctcl |
| 04/07/2005 | US20050074759 Methods for evaluation of in vitro aminoacyl tRNA production using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry |
| 04/07/2005 | US20050074758 Prokineticin polypeptides, related compositions and methods |
| 04/07/2005 | US20050074753 Contains modified ribose rings within RNA; solid phase synthesis; kits |
| 04/07/2005 | US20050074751 Binding viral protein during latency life cycle; binding of antibodies to excellular segments of protein; immobilization; removal of infecting cells; autoimmune disease, lupus, antiarthritic agents |
| 04/07/2005 | US20050074746 In vitro test to detect risk of preeclampsia |
| 04/07/2005 | US20050074745 Generating models to characterize selected aspects of metabolic pathways; enzyme characterization and biochemical analysis |
| 04/07/2005 | US20050074478 Attachment of molecules to surfaces |
| 04/07/2005 | US20050074463 Therapeutic vaccination method, mutated peptides of hiv reverse transciptase and their use for vaccination and diagnostic purposes |
| 04/07/2005 | US20050074435 Enriching stem and progenitor cells by positive or negative selection of hematopoietic cells from umbilical cord blood; culturing under proliferation conditions that increase differentiation potential |
| 04/07/2005 | US20050074430 recombinant virus genetically engineered to have hypoxia induced factor replicates selectively in hypoxic cells or tissues |
| 04/07/2005 | US20050074427 IL-17 like molecules and uses thereof |
| 04/07/2005 | US20050074419 Use of a chromoionophore and/or fluoroionophore for dyeing human keratin fibres, dyeing compositions and methods |
| 04/07/2005 | US20050072670 Biosensor |
| 04/07/2005 | DE10342373A1 Verfahren zur Synthese von Nukleinsäuren und deren Anwendung A process for the synthesis of nucleic acids and their uses |
| 04/07/2005 | DE10341812A1 Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung Differentially expressed in tumors gene products and their use |
| 04/07/2005 | CA2814269A1 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 04/07/2005 | CA2742134A1 Detection of human papilloma virus (hpv) utilizing invasive cleavage structure assays |
| 04/07/2005 | CA2707765A1 Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample |
| 04/07/2005 | CA2540732A1 Method and device for replicating arrays of cell colonies |
| 04/07/2005 | CA2540701A1 Proteins expressed in nk cells |
| 04/07/2005 | CA2540472A1 Method of in situ detection of proteins using aptamers |
| 04/07/2005 | CA2540405A1 Identification of polymorphisms in the epcr gene associated with thrombotic risk |
| 04/07/2005 | CA2540177A1 Seneca valley virus based compositions and methods for treating disease |
| 04/07/2005 | CA2540128A1 Quantification schemes for quantifying nucleic acids |
| 04/07/2005 | CA2540087A1 Amplification of polynucleotides by rolling circle amplification |
| 04/07/2005 | CA2540025A1 Method for conducting non-invasive early detection of colon cancer and/or of colon cancer precursor cells |
| 04/07/2005 | CA2539972A1 Antisense compound and method for selectively killing activated t cells |
| 04/07/2005 | CA2539947A1 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
| 04/07/2005 | CA2539886A1 Method for the specific rapid detection of beverage-spoiling micro-organisms |
| 04/07/2005 | CA2539824A1 Surface immobilized polyelectrolyte with multiple functional groups capable of covalently bonding to biomolecules |
| 04/07/2005 | CA2539752A1 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2005 | CA2539709A1 Novel therapeutic targets in cancer |
| 04/07/2005 | CA2539651A1 Synthetic lethal screen using rna interference |
| 04/07/2005 | CA2539551A1 Adrenergic receptor snp for improved milking characteristics |
| 04/07/2005 | CA2539434A1 Methods and compositions for the correlation of single nucleotide polymorphisms in the vitamin k epoxide reductase gene and warfarin dosage |
| 04/07/2005 | CA2539429A1 Quantification of biomolecular analytes by mass spectrometry using dendrimer internal standards |
| 04/07/2005 | CA2538852A1 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways |
| 04/07/2005 | CA2535922A1 Methods of synthesizing polynucleotides using thermostable enzymes |
| 04/07/2005 | CA2525217A1 Genetic markers for skatole metabolism |
| 04/06/2005 | EP1521083A2 Method for diagnosing and distinguishing stroke |
| 04/06/2005 | EP1520625A2 Reaction vessels |
| 04/06/2005 | EP1520619A2 Biochannel assay for hybridization with biomaterial |
| 04/06/2005 | EP1520247A1 Mutational profiles in hiv-1 protease correlated with phenotypic drug resistance |
| 04/06/2005 | EP1520246A2 Mutation detection and identification |
| 04/06/2005 | EP1520243A1 Peptide and protein identification method |
| 04/06/2005 | EP1520178A2 Method for enriching and tracking pathologic modified prions-proteins (prp sp sc /sp ) |
| 04/06/2005 | EP1520177A2 Method and reagent for specifically identifying and quantifying one or more proteins in a sample |
| 04/06/2005 | EP1520175A2 Oncolytic viruses as phenotyping agents for neoplasms |
| 04/06/2005 | EP1520157A1 A method of studying living cells |
| 04/06/2005 | EP1520050A2 Tr4/tr2 response elements |
| 04/06/2005 | EP1520049A1 Nucleic acid amplification method |
| 04/06/2005 | EP1520048A1 Screening for anti-ovulatory compounds |
| 04/06/2005 | EP1520047A1 Method for the characterisation of nucleic acid molecules |
| 04/06/2005 | EP1520046A2 Disease risk estimating method using sequence polymorphisms in a specific region of chromosome 19 |
| 04/06/2005 | EP1520045A1 Novel high density arrays and methods for analyte analysis |
| 04/06/2005 | EP1520044A2 Chromosome 6 and 9 genes involved in premature canities |
| 04/06/2005 | EP1520043A2 METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES |
| 04/06/2005 | EP1520042A2 Chromosome 3, 5 and 11 genes involved in premature canities |
| 04/06/2005 | EP1520041A2 Remanent magnetic paricles capable of binding a target substance, their production and uses thereof |
| 04/06/2005 | EP1520040A2 Microarrays displaying encoded molecules |
| 04/06/2005 | EP1520039A2 Mitochondrial polymorphisms linked to a predisposition for the development of inappropriate scarring or fibrosis |
| 04/06/2005 | EP1520038A2 Detection of circularized immobilized nucleic acid probes |
| 04/06/2005 | EP1520036A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 04/06/2005 | EP1520035A2 Method for detecting the von willebrand factor-cleaving protease activity of adamts-13 |
| 04/06/2005 | EP1520034A1 Enzyme-based monitoring device for the thermal processing of objects |
| 04/06/2005 | EP1520033A1 Detection of microorganisms with holographic sensor |
| 04/06/2005 | EP1520032A2 Lung cancer therapeutics and diagnostics |
| 04/06/2005 | EP1520024A1 Modified par receptors, their preparation and their uses for selecting compounds which modulate par activity |
| 04/06/2005 | EP1520022A2 Rna-interference by single-stranded rna molecules |
| 04/06/2005 | EP1520019A2 Adapter-directed display system |
| 04/06/2005 | EP1520015A2 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/06/2005 | EP1520010A2 Systems and methods for detection of nuclear receptor function using reporter enzyme mutant complementation |
| 04/06/2005 | EP1519956A2 Epha2 monoclonal antibodies and methods of use thereof |
| 04/06/2005 | EP1519742A2 Osteoclast-associated receptor |
| 04/06/2005 | EP1519725A2 Methods for targeting quadruplex dna |
| 04/06/2005 | EP1487996A4 Multiplex detection of biological materials in a sample |
| 04/06/2005 | EP1432987A4 Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection |
| 04/06/2005 | EP1412530A4 Ratio-based oligonucleotide probe selection |
| 04/06/2005 | EP1407050A4 Method for rapid amplification of dna |
| 04/06/2005 | EP1352080A4 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders |
| 04/06/2005 | EP1317570B1 Pcr reaction mixture for fluorescence-based gene analysis and gene mutation analysis |
| 04/06/2005 | EP1244810A4 Methods and systems for monitoring intracellular binding reactions |
| 04/06/2005 | EP1244776B1 Tetrahydropyrimidine oxygenase gene, polypeptides encoded by said gene and method for producing the same |
| 04/06/2005 | EP1224469B1 Method of screening for inhibitors of asp2 |
| 04/06/2005 | EP1224304A4 Methods of manipulating and sequencing nucleic acid molecules using transposition and recombination |
| 04/06/2005 | EP1218494B1 Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
| 04/06/2005 | EP1162993B1 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 04/06/2005 | EP0970194B1 Method of cell surface activation and inhibition |
| 04/06/2005 | CN1605028A Automated system and method for processing specimens to extract samples for both liquid-based and slide-based testing |
| 04/06/2005 | CN1605027A Methods and compositions for treatment of central nervous system disorders |
| 04/06/2005 | CN1605023A Filtration system and method for obtaining a cytology layer |